This morning, the Federal Circuit released two nonprecedential opinions and one nonprecedential order. One opinion comes in a patent case appealed from the Patent Trial and Appeal Board, and one comes in response to a petition for review of a decision of the Merit Systems Protection Board. The order dismisses an appeal. Here are the introductions to the opinions as well as a link to the dismissal.
Medmix Switzerland AG v. Squires (Nonprecedential)
Medmix Switzerland AG (“medmix”) appeals from a final written decision of the United States Patent Trial and Appeal Board (“the Board”) determining that claims 1–3, 9–13, and 16–17 of U.S. Patent 9,010,578 (“the ’578 patent”) had been shown to be unpatentable as obvious. Xinial Sys. Gmbh & Co. Kg v. Medmix Switzerland Ag, No. IPR2022-01462, 2024 WL 714900, at *1 (P.T.A.B. Feb. 21, 2024) (“Decision”). For the following reasons, we affirm.
McGowan v. Office of Personnel Management (Nonprecedential)
Val McGowan appeals a decision of the Merit Systems Protection Board affirming the denial of his application for disability retirement benefits by the Office of Personnel Management. We affirm.